Literature DB >> 19754377

Cross-talk between oxidative stress and pro-inflammatory cytokines in acute pancreatitis: a key role for protein phosphatases.

Javier Escobar1, Javier Pereda, Alessandro Arduini, Juan Sandoval, Luis Sabater, Luis Aparisi, Gerardo López-Rodas, Juan Sastre.   

Abstract

Acute pancreatitis is an acute inflammatory process localized in the pancreatic gland that frequently involves peripancreatic tissues. It is still under investigation why an episode of acute pancreatitis remains mild affecting only the pancreas or progresses to a severe form leading to multiple organ failure and death. Proinflammatory cytokines and oxidative stress play a pivotal role in the early pathophysiological events of the disease. Cytokines such as interleukin 1beta and tumor necrosis factor alpha initiate and propagate almost all consequences of the systemic inflammatory response syndrome. On the other hand, depletion of pancreatic glutathione is an early hallmark of acute pancreatitis and reactive oxygen species are also associated with the inflammatory process. Changes in thiol homestasis and redox signaling decisively contribute to amplification of the inflammatory cascade through mitogen activated protein kinase (MAP kinase) pathways. This review focuses on the relationship between oxidative stress, pro-inflammatory cytokines and MAP kinase/protein phosphatase pathways as major modulators of the inflammatory response in acute pancreatitis. Redox sensitive signal transduction mediated by inactivation of protein phosphatases, particularly protein tyrosin phosphatases, is highlighted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754377     DOI: 10.2174/138161209789058075

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  32 in total

1.  Protein phosphatases and chromatin modifying complexes in the inflammatory cascade in acute pancreatitis.

Authors:  Javier Escobar; Javier Pereda; Alessandro Arduini; Juan Sandoval; Luis Sabater; Luis Aparisi; Gerardo López-Rodas; Juan Sastre
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-06-06

2.  Inflammatory role of the acinar cells during acute pancreatitis.

Authors:  Isabel De Dios
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-02-06

Review 3.  Immunomodulatory basis of antioxidant therapy and its future prospects: an appraisal.

Authors:  Y Ajith; U Dimri; S K Dixit; Shanker K Singh; A Gopalakrishnan; E Madhesh; J B Rajesh; S G Sangeetha
Journal:  Inflammopharmacology       Date:  2017-09-01       Impact factor: 4.473

4.  Protective effects of sivelestat in a caerulein-induced rat acute pancreatitis model.

Authors:  Jun Cao; Quanyan Liu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 5.  Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

6.  Diabetes mellitus: channeling care through cellular discovery.

Authors:  Kenneth Maiese; Yan Chen Shang; Zhao Zhong Chong; Jinling Hou
Journal:  Curr Neurovasc Res       Date:  2010-02       Impact factor: 1.990

7.  Pomalidomide suppresses cerulein-induced acute pancreatitis in mice.

Authors:  Ming Jen Tsai; Chinpiao Chen; Sung-Ho Chen; Yen Ta Huang; Ted H Chiu
Journal:  J Gastroenterol       Date:  2011-03-25       Impact factor: 7.527

Review 8.  Oxidative stress and inflammatory signaling in cerulein pancreatitis.

Authors:  Ji Hoon Yu; Hyeyoung Kim
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

9.  Down-regulation of IL-6, IL-8, TNF-α and IL-1β by glucosamine in HaCaT cells, but not in the presence of TNF-α

Authors:  Kun Park; Ji-Hye Lee; Ho-Chan Cho; Sun-Young Cho; Jae-We Cho
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

Review 10.  Experimental and clinical evidence of antioxidant therapy in acute pancreatitis.

Authors:  Mukaddes Esrefoglu
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.